Brainstorm Cell Therapeutics Inc.

8-K Director or officer change; Regulation FD disclosure Jul 30, 2026 8-K Director or officer change; Regulation FD disclosure May 28, 2026 8-K Results of operations (earnings release) May 15, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Results of operations (earnings release) Mar 31, 2026 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change Feb 27, 2026 8-K Entered a material agreement; Unregistered sale of equity Feb 13, 2026 8-K Entered a material agreement; Unregistered sale of equity Jan 9, 2026 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity Nov 14, 2025 8-K Entered a material agreement; Unregistered sale of equity Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Delisting notice or listing-rule failure Jul 17, 2025 8-K Director or officer change; Shareholder vote results Jun 25, 2025 8-K Other events Jun 16, 2025 8-K Other events May 19, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) May 15, 2025 8-K Amended charter or bylaws; Item 5.08 Apr 21, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025 8-K Entered a material agreement; Unregistered sale of equity Mar 31, 2025 8-K Other events Mar 27, 2025 8-K Delisting notice or listing-rule failure Jan 21, 2025 8-K Delisting notice or listing-rule failure Jan 15, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Delisting notice or listing-rule failure Oct 30, 2024 8-K Delisting notice or listing-rule failure; Modified rights of security holders; Amended charter or bylaws Oct 1, 2024 8-K Regulation FD disclosure Oct 1, 2024 8-K Other events Sep 26, 2024 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Sep 16, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Results of operations (earnings release) Aug 14, 2024 8-K Item 5.08 Jul 30, 2024 8-K Delisting notice or listing-rule failure Jul 19, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Jun 28, 2024 8-K Other events Jun 26, 2024